Growth, clinical and neurodevelopmental outcomes at school age are similar for children who received 1-year lamivudine or lopinavir/ritonavir HIV prophylaxis in early life

por Nagot, Nicolas, Singata-Madliki, Mandisa, Cournil, Amandine, Nalugya, Joyce, Tassembedo, Souleymane, Quillet, Catherine, Tonga, Melany W., Tumwine, James, Meda, Nicolas, Kankasa, Chipepo, Mwiya, Mwiya, Bangirana, Paul, Peries, Marianne, Batting, Joanne, Engebretsen, Ingunn M. S., Tylleskär, Thorkild, Perre, Philippe Vande, Ndeezi, Grace, Molès, Jean-Pierre
Publicado 2021